Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Joshua Natoli"


25 mentions found


On Thursday's "Ask Halftime," traders answered questions from CNBC Pro subscribers about which stocks, bonds and funds to buy, hold or sell. Bill Baruch of Blue Line Futures laid out his technical thesis on how Bank of America and JPMorgan Chase could break out if either were to trade above current share price resistance levels. Finally, Brenda Vingiello of Sand Hill Global Advisors shared why she prefers Chevron over Exxon Mobil as an energy play.
Persons: Bill Baruch, JPMorgan Chase, Brenda Vingiello Organizations: CNBC Pro, Blue, Bank of America, JPMorgan, Global Advisors, Chevron, Exxon Mobil Locations: Sand
On Thursday's "Ask Halftime," traders answered questions from CNBC Pro subscribers about which stocks and exchange-traded funds to buy, hold or sell. Aureus Asset Management's Karen Firestone shared her thesis on why Lowe's and Home Depot could get a boost from earnings and increased consumer spending. Rob Sechan of NewEdge Wealth discussed why he sees Broadcom as a reasonably priced beneficiary of the artificial intelligence boom. Finally, Jim Lebenthal of Cerity Partners explained why holders of Cleveland-Cliffs should not have to wait long before they start seeing returns.
Persons: Karen Firestone, Rob Sechan, Jim Lebenthal Organizations: CNBC Pro, NewEdge, Broadcom, Cerity Partners Locations: Cleveland
Monday, July 24, 2023: Cramer adds this stock to the BullpenJim Cramer and Jeff Marks share their outlook for the market as Wall Street awaits another potential interest rate hike from the Federal Reserve. Jim explains why he added a stock to the Club's B ullpen and urges members to keep an eye on it. Jim and Jeff break down each of the nine portfolio holdings reporting earnings this week.
Persons: Cramer, Jim Cramer, Jeff Marks, Jim, Jeff Organizations: Federal Reserve
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDisney trades flat after Iger contract extension. Here's what the pros are sayingJim Cramer, Michael Nathanson of SVB MoffettNathanson, Jim Lebenthal of Cerity Partners and Alan Gould of Loop Capital discussed Disney after it announced a contract extension with CEO Bob Iger through 2026.
Persons: Jim Cramer, Michael Nathanson, SVB MoffettNathanson, Jim Lebenthal, Alan Gould, Bob Iger Organizations: Cerity Partners, Loop Capital, Disney
Market Movers rounded up the best reactions from investors and analysts on Disney . The pros, including Jim Cramer , discussed the theme park operator after it extended CEO Bob Iger's contract through 2026. Iger returned to the post late last year, following the sudden departure of former CEO Bob Chapek. Iger admitted navigating the media landscape had proven harder than he had expected when he was renamed CEO. Disney shares hardly budged after news of the contract extension surfaced and are up around 1% year to date.
Persons: Jim Cramer, Bob Iger's, Iger, Bob Chapek, CNBC's David Faber Organizations: Disney, Trust
Thursday, July 13, 2023: Cramer shares why he's waiting to put cash to workJim Cramer and Jeff Marks share why the market is liking declines in some key inflation data but warn the labor market is still too hot for the Federal Reserve. Jim discusses why is waiting patiently before doing more buying. Jim also breaks down two Club stocks on the heels of fresh analyst upgrades.
Persons: Cramer, Jim Cramer, Jeff Marks, Jim Organizations: Federal Reserve
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBiogen shares fall after Alzheimer's drug approval. Here's what the pros are sayingMichael Yee of Jefferies, Chris Raymond of Piper Sandler, Kevin Simpson of Capital Wealth Planning, Steve Weiss of Short Hills Capital and Jim Lebenthal of Cerity Partners discussed Biogen after the FDA approved its Alzheimer's drug.
Persons: Michael Yee, Jefferies, Chris Raymond, Piper Sandler, Kevin Simpson, Steve Weiss, Jim Lebenthal Organizations: Capital Wealth, Short Hills Capital, Cerity Partners, FDA
Market Movers rounded up the best reactions from investors and analysts on Biogen . The experts discussed the biotech company after the Food and Drug Administration approved its Alzheimer's treatment Leqembi , paving the way for broader Medicare coverage. The drug slowed cognitive decline in trials, but poses risks of brain swelling and bleeding and comes with a $26,500 per year price tag. Biogen collaborated with Japanese pharmaceutical company Eisai to make Leqembi. Despite the approval, Biogen shares slid more than 3% by Friday's market close and are down nearly 10% over the past month.
Persons: Biogen Organizations: Food and Drug Administration
Friday, July 7, 2023: The Club says stay the course in two downgraded stocksJeff Marks shares why the market remains largely unchanged following June's jobs report missing estimates. Jeff discusses two portfolio stocks hit with fresh downgrades and why the Club is not losing faith in them. Finally, Jeff explains why he and Jim Cramer are growing weary of one entertainment holding.
Persons: Marks, Jeff, Jim Cramer
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMeta hits 17-month high after Threads platform launch. Here's what the pros are sayingJim Cramer, Josh Brown of Ritholtz Wealth Management, Sarat Sethi of DCLA and Joe Terranova of Virtus Investment Partners discussed Meta after the company rolled out its Threads social media platform.
Persons: Jim Cramer, Josh Brown, Sarat Sethi, DCLA, Joe Terranova Organizations: Ritholtz Wealth, Virtus Investment Partners
Market Movers rounded up the best reactions from investors and analysts on Meta Platforms . The experts, including Jim Cramer , discussed the social media company a day after it launched the Threads platform to rival Twitter. The rollout caught the eye of KeyBanc, which raised its price target on Meta to $335 from $280. Also, Ivan Feinseth from Tigress Financial, reiterated a buy rating on Meta, with a price target of $380. During Thursday's session, Meta's stock matched a 17-month high it had hit the previous day.
Persons: Jim Cramer, Ivan Feinseth Organizations: Meta, Twitter, Tigress
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPioneer, Bristol-Myers and more: CNBC's 'Halftime Report' traders answer your questionsCNBC's Halftime traders Sarat Sethi of DCLA, Joe Terranova of Virtus Investment Partners and Amy Raskin of Chevy Chase Trust answer investment-related questions from CNBC Pro subscribers. Look out for an email where you can submit your questions directly to the Halftime team.
Persons: Myers, Sarat Sethi, DCLA, Joe Terranova, Amy Raskin Organizations: Virtus Investment Partners, Chevy Chase Trust, CNBC Pro Locations: Bristol
On Thursday's "Ask Halftime," traders answered questions from CNBC Pro subscribers about which stocks, bonds and funds to buy, hold or sell. Sarat Sethi of DCLA shared why he thinks Pioneer Natural Resources is "part of a core portfolio." Virtus Investment Partners' Joe Terranova listed several health-care stocks that could outperform Bristol-Myers Squibb in the sector. Finally, Amy Raskin of Chevy Chase Trust explained why now is a good time to buy bonds.
Persons: Sarat Sethi, DCLA, Joe Terranova, Amy Raskin Organizations: CNBC Pro, Resources, Investment Partners, Bristol, Myers Squibb, Chevy Chase Trust
Thursday, July 6, 2023: Cramer says this surging stock has much more upsideJim Cramer and Jeff Marks talk about their market outlook after the June ADP private payrolls report was more than double the estimates. Jim discusses why he is staying long in two megacap tech stocks which just received fresh analyst price target hikes. Finally, Jim shares why he is bullish on a health-care company in the portfolio.
Persons: Cramer, Jim Cramer, Jeff Marks, Jim
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNetflix hits highest level in 17 months. Here's what the pros are sayingJim Cramer, Joe Terranova of Virtus Investment Partners, Jenny Harrington of Gilman Hill Asset Management, Steve Weiss of Short Hills Capital and Jim Lebenthal of Cerity Partners discussed Netflix after the stock surged to its highest level since February 2022 following an upgrade from Goldman Sachs.
Persons: Jim Cramer, Joe Terranova, Jenny Harrington, Steve Weiss, Jim Lebenthal, Goldman Sachs Organizations: Netflix, Virtus Investment Partners, Asset Management, Short Hills Capital, Cerity Partners, Goldman
Wednesday, July 5, 2023: Cramer trims this stock after recent rallyJim Cramer and Jeff Marks discuss why they think the second half of 2023 is not set up to be as successful for the market as the first six months of the year. Jim shares why he his trimming a consumer staple stock in the portfolio on the heels of a rally. Jim also breaks down his near-term outlook for the bank holdings in the Charitable Trust.
Persons: Cramer, Jim Cramer, Jeff Marks, Jim Organizations: Charitable Trust
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRoger Bayston on using blockchain technology to find investment opportunitiesCNBC's Tanaya Macheel sits down with Franklin Templeton Head of Digital Assets Roger Bayston at the VISION 2023 conference taking place this week in Austin, Texas. VISION is the longest-running cryptocurrency investment conference for financial professionals and investors in the industry. Bayston discusses investment opportunities using blockchain technology and finding new applications for Bitcoin and Ethereum.
Persons: Roger Bayston, CNBC's, Macheel, Franklin Templeton, Digital Assets Roger Bayston, Bayston Organizations: Franklin Templeton Head, Digital Assets Locations: Austin , Texas
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailScott Helfstein on staying diversified when investing in cryptoCNBC's Tanaya Macheel sits down with Morgan Stanley Head of Market Strategy Scott Helfstein at the VISION 2023 conference taking place this week in Austin, Texas. VISION is the longest-running cryptocurrency investment conference for financial professionals and investors in the industry. Helfstein discusses blockchain technology and artificial intelligence, as well as how to keep a broad portfolio when investing in cryptocurrency.
Persons: Scott Helfstein, Macheel, Morgan Stanley, Helfstein Locations: Austin , Texas, cryptocurrency
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNvidia gets price target hike amid 10% gain this week. How to play the stockJim Cramer, Joseph Moore of Morgan Stanley, Josh Brown of Ritholtz Wealth Management and Jason Snipe of Odyssey Capital Advisors on what they think about Nvidia receiving a price target hike even after its massive run.
Persons: Jim Cramer, Joseph Moore, Morgan Stanley, Josh Brown, Jason Snipe Organizations: Nvidia, Ritholtz Wealth Management, Odyssey Capital Advisors
Market Movers rounded up the best reactions from investors and analysts on Nvidia . The experts, including Jim Cramer , discussed the chipmaker after Morgan Stanley named Nvidia its top artificial intelligence pick over AMD . Joseph Moore, the analyst who made the call, is also hiking his price target on Nvidia to $500 from $450, telling CNBC that the company's growing customer base could lift the stock higher. The stock finished the trading day with a small gain of 0.09%, good enough for a 10% jump on the week.
Persons: Jim Cramer, Morgan Stanley, Joseph Moore Organizations: Nvidia, AMD, CNBC
Friday, June 16, 2023: Cramer trims this stock amid overbought market conditionsJim Cramer and Jeff Marks say it's time for investors to exercise caution and stay disciplined as the S&P Oscillator shows overbought market conditions. Jim discusses why he is selling some shares of an industrial gas company in the portfolio. He also is looking to possibly trim a few more Club stocks next week that have been on the rise.
Persons: Cramer, Jim Cramer, Jeff Marks, Jim
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCNBC Pro Exclusive: Josh Brown shares his "common sense" approach to investing in cryptocurrencyCNBC's Tanaya Macheel sits down exclusively with Ritholtz Wealth Management CEO Josh Brown at the VISION 2023 conference taking place this week in Austin, Texas. VISION is the longest-running cryptocurrency investment conference for financial professionals and investors in the industry. Brown discusses why he thinks cryptocurrency could have a market boom similar to artificial intelligence and shares what he says is the smartest way to invest in the sector.
Persons: Josh Brown, Macheel, Brown, cryptocurrency Organizations: cryptocurrency, Ritholtz Wealth Locations: Austin , Texas
Wednesday, June 7, 2023: Cramer thinks this stock can rally higherJim Cramer and Jeff Marks break down the rally in megacap tech and which stock looks most appealing out of the group. Jim shares his thesis on why one company in the portfolio could rally higher. Finally, Jim gives his outlook on the health care names in the Charitable Trust.
Persons: Cramer, Jim Cramer, Jeff Marks, Jim Organizations: Charitable Trust
Market Movers rounded up the best reactions from investors and analysts on Apple . The experts, including Jim Cramer , discussed the tech giant after it unveiled its new mixed-reality Vision Pro headset Monday . Davidson downgraded the stock to neutral from buy that evening, saying the good news from Vision Pro is already priced into the shares and noting there are structural challenges around consumer adoption of the headset. Apple shares closed down 0.2% Tuesday. The stock is currently held in Cramer's Charitable Trust.
Persons: Jim Cramer, D.A, Davidson Organizations: Apple, Vision, Charitable
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailApple trades flat after analyst downgrade. Here's how to play the stockJim Cramer, Toni Sacconaghi of Bernstein, Josh Brown of Ritholtz Wealth Management, Brenda Vingiello of Sand Hill Global Advisors, Stephanie Link of Hightower Advisors, Rob Sechan of NewEdge Wealth and Tom Forte of D.A. Davidson & Co. on what they think about Apple after the stock was hit with a downgrade as they unveiled a new mixed-reality headset.
Persons: Jim Cramer, Toni Sacconaghi, Bernstein, Josh Brown, Brenda Vingiello, Stephanie Link, Rob Sechan, Tom Forte, D.A Organizations: Apple, Ritholtz Wealth Management, Global Advisors, Hightower Advisors, Davidson Locations: Sand
Total: 25